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I am the dirt farmer here at the meeting—operating on the lowest rung of the
biotech ladder! As operators of a farm in northwest Iowa, my brother and I use
the products of biotechnology and try to make them commercially viable. We
have one employee, so three of us make a living from about 4,000 acres of corn
and soybeans. We grow seed beans for three seed companies, all genetically
altered. And we grow tofu beans that are exported directly to Japan. We have
commodity corn and waxy corn for salad dressing and mayonnaise, corn for
juvenile poultry, and we also grow pharmaceutical corn.
We have been planting Bt corn and Roundup Ready® soybeans for the last
3␣ or 4 years. About 80% of the soybeans this year, and some people say more,
in␣ this country will be genetically altered. Approximately 25% of the corn will
also be genetically altered in this country. This is the most rapidly adopted
technology that has ever come to agriculture, including steam power, electricity,
commercial fertilizer, and hybrid corn. None of those innovations were adapted
as fast as biotechnology.
MORE TIME FOR WHAT MATTERS
With Roundup Ready® beans we have a $12/acre savings right from the start,
which, in today’s agricultural economy, is very important to the family farmer.
When I was growing up, I spent my summers walking soybean fields with
a␣ garden hoe, cutting out the weeds that were competing for nutrients and
moisture. Because of biotechnology and Roundup Ready® soy, my children are
involved in Little League baseball and the swim team, and attend dance lessons,
etc. And, as a parent, because of Roundup Ready® beans, I get to watch them.
As a user at the ground level, biotechnology gives me time, the most precious
commodity that any of us can find today. It helps me be a better husband and a
better father, and that is important to me.
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BIOTECH AND ZERO TILLAGE
Of course, it is environmentally friendly. Roundup is a contact herbicide.
It␣ does not function in the soil, so it doesn’t get into the ground water, unlike
other crop-protection products that have been available for the past 15 to
20␣ years. The Roundup Ready® technology also allows us to no-till drill our
soybeans directly into the stubble of the previous crop. No-till crop production
has been around for 20 years; but it worked well for only 2 or 3 years before the
weed pattern would shift and give problems. With Roundup Ready® soybeans,
continuous no-till is possible. It is the technology that will be written about
500␣ years from now. From the first time that a human being took a stick, put
a␣ hole in the ground and planted a seed and became the first farmer thousands
of years ago, farming has always been connected with soil erosion. In Europe
where they have been farming for three or four millennia, soil erosion is a very
serious problem. In this country, we have lost half of our topsoil in the past
150␣ years. When historians write about this period 500 years from now, it will
not be about Bill Clinton or George Bush or Saddam Hussein, it will be about
how biotechnology allowed us to go to no-till and stop soil erosion—stop the
deterioration of the food factory of the earth.
GPS AND TRACEABILITY
Today’s tractors and combines use global positioning system (GPS) technology.
The steering of the tractor is controlled via microprocessors such that when it
gets to the end of the field I have to turn it around and relocate the line and
it␣ then takes off on its own, planting perfectly straight rows in any direction
and␣ any heading that you wish to log in the computer. This will be part of the
traceability system. With GPS equipment on board we record what the seed is—
the genetics come with that information—we document the longitude and
latitude of where that seed is planted and when it is planted. The information
is␣ time-stamped and eventually will be available to everybody in the value chain
for traceability efforts. The average farm tractor and the average combine that
is␣ harvesting crops have more computing power in the cab than the rockets we
sent to the moon and back.
BT CORN AND TIME AVAILABLE FOR HARVEST
The leaves of Bt corn plants are toxic to the larvae of European corn borer,
which is great, because this insect is the most serious pest for corn. On the
other hand, in the real world where I live that is not the chief benefit. To me
the␣ longer harvest window—because of improved late-season plant health—
is␣ very critical. If my harvesting goes from a 2-week period to a 4-week period,
it means that I can use the same $200,000 combine on twice as many acres or
I␣ can use a smaller combine on the acres I have today. That has a greater
financial benefit effect for me than anything else the Bt technology brings.
It␣ is␣ critical for farmers everywhere. And of course, again, the technology is
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environmentally friendly. When we used to spray fields that had corn borer
in␣ them, we killed all the insects. Now the plant itself is the herbicide, and it
is␣ specific to only that insect pest, and beneficial insects are not harmed in
any␣ way.
REVITALIZED RURAL COMMUNITIES
In 2001, we were among the first to grow, under contract, corn that synthesizes
a pharmaceutical for the treatment of cystic fibrosis patients; we grew it again in
2002 for phase-3 clinical trials in Europe. This is going to be a very important
part of rural development and rural revitalization. Biotechnology eventually is
going to take a lot of the plywood down off the small towns in the corn belt. It
will take us from a low-margin mature-commodity business to a higher-margin
management-responsive new business to allow farmers to generate some real
dollars. Accordingly, we are trying to set up a technology-support program in
Iowa. In our little group, we have written our SOPs for experimental transgenic
crop production. We are also growing some tobacco that is genetically altered to
not have nicotine, and in 2002 we will grow some safflower crops from Canada
that in 2003 will produce another human pharmaceutical.
Thus, biotechnology is opening the door of opportunity for development
of␣ family farms in rural communities. And this technology, as it expands and
grows in the corn belt, will not bring traditional unskilled, low paying jobs.
Instead it will draw degreed people back into the rural states. It will change the
flavor of Minnesota, Iowa and other states that grow traditional commodity
crops.
About 450 drugs are in the pipeline. We are involved with the first one, but
many more will follow in the next 24 to 48 months. We are excited about this,
as are lots of other farmers. In Iowa we are taking a three-part platform to try
to␣ draw industry back into the corn belt. Almost all of the tech companies tell
us that it makes sense to produce these biotech pharmaceutical and industrial
enzyme crops in the corn belt, especially in areas with low hail rates (hail is
the␣ #1 weather problem for these crops). Corn is the domesticated crop of
choice for drug production, and we think that we can enhance the potential of
traditional corn-growing areas. Novecta is a certification program for producers,
put in place by the Iowa and Illinois Corn Growers Associations. Through self-
funding and our check-off money, we have devoted $600,000 to develop
web-based coursework for farmers to become qualified in technologies to
reduce risks for biotech providers in producing these crops. Written exams will
be involved, and farmers who obtain certification will receive a card saying that
they are certified producers of a particular industrial enzyme or pharmaceutical
who understand the technology, the SOPs, and critical aspects of containment.
One of the reasons that we got the contract to grow pharmaceutical corn is that
we convinced the company that we had a 100% identity-preservation system.
Because of Starlink™, that is the number-one issue. We found that our
Horan
228 Integrating Agriculture, Medicine and Food for Future Health
traditional commodity system was totally inappropriate for these high-value
crops, therefore, we have dedicated planting machinery, dedicated husbandry,
dedicated harvesting equipment, dedicated transportation and storage
equipment so that our pharmaceutical production gets nowhere near our
commodity corn. Our SOPs are written around that.
The idea of a technician program came from a community college in Iowa
that is working with an animal pharmaceutical company to set up a curriculum
to train technicians for animal-vaccine production in that company. We have
been working with Iowa State University, the community college system and
the University of Iowa to put together a program that will train 2-year
technicians on one hand through to advanced biochemists on the other end
of␣ the spectrum such that they all understand their place in the chain, why
they␣ do what they do and why it is important. Iowa is the only state that has
a␣ parallel-constructed curriculum.
And lastly, the third leg is a multi-tenant biologics facility. A $20-million
facility is under construction at the Research Park in Ames, Iowa. Companies
will take their table-top test-tube work, which they can replicate in the lab, to
this facility and lease a suite for the time required to commercialize the product.
This facility will be large enough to run one tenth of a commercial batch to see
if it is scalable:
• Do they have the right equipment, the right process, to scale, and if they
do, what does it cost? How much time does it take?
• What percentage of product do they get?
All such issues can be figured out at this facility, which is the only one of its
kind in the world. This is Iowa’s approach to this situation.
THE REASON FOR THIS CONFERENCE
A letter was sent to my brother and me by a mother who has two sick children,
after she saw an article written about us:
My step-dad subscribes to Top Producer and forwarded the January
2002 issue to me. My son Justin, age 13, and daughter Candice, age 8,
have cystic fibrosis. We were thrilled to see your involvement in the
fight against cystic fibrosis and other diseases. Thank you for your
dedication thus far. I’m sure it hasn’t been easy. Justin wrote a book,
enclosed, when he was 8 years old to explain to his friends why he
couldn’t do some of the things that they could do. The title is 99 Bottles
of Pills on the Wall and it’s illustrated by Justin. He wants you to have
a copy because of your help with this disease. Justin prays about this
disease. Thank you for being available for His purposes. God bless you.
Jennifer Colson
This is the reason for this conference. Agricultural biotechnology is where the
rubber meets the road.
